98 related articles for article (PubMed ID: 30888817)
1. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.
Kirsch P; Jakob V; Oberhausen K; Stein SC; Cucarro I; Schulz TF; Empting M
J Med Chem; 2019 Apr; 62(8):3924-3939. PubMed ID: 30888817
[TBL] [Abstract][Full Text] [Related]
2. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.
Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M
Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated Herpesvirus.
Kirsch P; Jakob V; Elgaher WAM; Walt C; Oberhausen K; Schulz TF; Empting M
ACS Chem Biol; 2020 Feb; 15(2):388-395. PubMed ID: 31944659
[TBL] [Abstract][Full Text] [Related]
4. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
[TBL] [Abstract][Full Text] [Related]
5. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
6. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
7. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA.
Messick TE; Tolvinski L; Zartler ER; Moberg A; Frostell Å; Smith GR; Reitz AB; Lieberman PM
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290261
[TBL] [Abstract][Full Text] [Related]
8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
Weidner-Glunde M; Mariggiò G; Schulz TF
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
11. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
12. Crystallization, room-temperature X-ray diffraction and preliminary analysis of Kaposi's sarcoma herpesvirus LANA bound to DNA.
Hellert J; Krausze J; Schulz TF; Lührs T
Acta Crystallogr F Struct Biol Commun; 2014 Nov; 70(Pt 11):1570-4. PubMed ID: 25372834
[TBL] [Abstract][Full Text] [Related]
13. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
14. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
Hu J; Garber AC; Renne R
J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
[TBL] [Abstract][Full Text] [Related]
15. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
16. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
17. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
18. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Kaul R; Verma SC; Robertson ES
Virology; 2007 Aug; 364(2):317-29. PubMed ID: 17434559
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
[TBL] [Abstract][Full Text] [Related]
20. Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.
Kelley-Clarke B; Ballestas ME; Srinivasan V; Barbera AJ; Komatsu T; Harris TA; Kazanjian M; Kaye KM
J Virol; 2007 Apr; 81(8):4348-56. PubMed ID: 17287261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
